In summary, our research illustrates that PRMT6 acts as an epigenetic regulator, suppressing TRAF6 transcription through histone arginine methylation (H3R2me2a) to inhibit the ubiquitination and degradation of EZH2, thereby promoting invasion and migration of glioblastoma cells. Here, EZH2 is linked to glioblastoma.